These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1828521)

  • 1. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.
    Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL
    Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
    Gradin K; Pettersson A; Hedner T; Persson B
    J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Aug; 185(1):11-8. PubMed ID: 2171956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat.
    Petty MA; Kintz J; Di Francesco GF; Fozard JR
    J Auton Pharmacol; 1988 Dec; 8(4):267-76. PubMed ID: 2855330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the adrenal medulla in the metabolic and pressor actions of 8-OH-DPAT.
    Bouhelal R; Mir AK
    Br J Pharmacol; 1992 Jan; 105(1):159-63. PubMed ID: 1534503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
    Martin GE; Lis EV
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B; Kotai E; Weisz E; Singer EA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.